Lea T Drye Selected Research

Citalopram

1/2017	Characterizing Highly Benefited Patients in Randomized Clinical Trials.
5/2016	Heterogeneity of Treatment Response to Citalopram for Patients With Alzheimer's Disease With Aggression or Agitation: The CitAD Randomized Clinical Trial.
5/2016	Effects of Citalopram on Neuropsychiatric Symptoms in Alzheimer's Dementia: Evidence From the CitAD Study.
3/2016	Citalopram for the Treatment of Agitation in Alzheimer Dementia: Genetic Influences.
3/2016	Sedation mediates part of Citalopram's effect on agitation in Alzheimer's disease.
1/2016	R- and S-citalopram concentrations have differential effects on neuropsychiatric scores in elders with dementia and agitation.
1/2016	Principal components analysis of agitation outcomes in Alzheimer's disease.
12/2015	Change in agitation in Alzheimer's disease in the placebo arm of a nine-week controlled trial.
11/2015	Time to Response to Citalopram Treatment for Agitation in Alzheimer Disease.
2/2014	Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lea T Drye Research Topics

Disease

25	Alzheimer Disease (Alzheimer's Disease) 11/2019 - 02/2010
5	Dementia (Dementias) 05/2016 - 06/2013
5	Uveitis 10/2015 - 03/2012
2	Parkinson Disease (Parkinson's Disease) 01/2018 - 10/2015
2	Dyskinesias (Dyskinesia) 01/2018 - 10/2015
2	Asthma (Bronchial Asthma) 11/2016 - 12/2014
2	Panuveitis 10/2015 - 10/2014
1	Tremor (Tremors) 01/2018
1	Cognitive Dysfunction 05/2016
1	Mental Disorders (Mental Disorder) 05/2016
1	Hallucinations (Hallucination) 05/2016
1	Posterior Uveitis 10/2015
1	Intermediate Uveitis (Chronic Cyclitis) 10/2015
1	Inflammation (Inflammations) 10/2015
1	Infections 12/2013
1	Vision Disorders (Hemeralopia) 12/2013
1	Weight Loss (Weight Reduction) 08/2013
1	Mood Disorders (Mood Disorder) 06/2011
1	Dizziness (Lightheadedness) 04/2010
1	Diarrhea 04/2010

Drug/Important Bio-Agent (IBA)

12	Citalopram FDA LinkGeneric 01/2017 - 01/2012
6	Sertraline (Zoloft)FDA LinkGeneric 01/2014 - 02/2010
5	SteroidsIBA 10/2015 - 03/2012
4	Antidepressive Agents (Antidepressants)IBA 12/2012 - 02/2010
3	Methylphenidate (Ritalin)FDA LinkGeneric 02/2014 - 06/2013
2	Fluocinolone Acetonide (Capex)FDA LinkGeneric 10/2015 - 10/2014
1	Escitalopram FDA Link 11/2019
1	A 7 (A-7)IBA 01/2018
1	salicylhydroxamic acid (SHAM)IBA 11/2016
1	Lorazepam (Ativan)FDA LinkGeneric 05/2016
1	Therapeutic UsesIBA 05/2016
1	Hypnotics and Sedatives (Sedatives)IBA 03/2016
1	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2015
1	Interleukin-10 (Interleukin 10)IBA 12/2013
1	CytokinesIBA 12/2013
1	Apolipoproteins E (ApoE)IBA 01/2012
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2012
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 04/2010

Therapy/Procedure

3	Therapeutics 01/2018 - 10/2014
2	Deep Brain Stimulation 01/2018 - 10/2015
1	Drug Therapy (Chemotherapy) 01/2018
1	Continuous Positive Airway Pressure 11/2016
1	Long-Term Care 05/2016
1	Vitrectomy 04/2012